GB1525765A - Injectable solution - Google Patents

Injectable solution

Info

Publication number
GB1525765A
GB1525765A GB33481/76A GB3348176A GB1525765A GB 1525765 A GB1525765 A GB 1525765A GB 33481/76 A GB33481/76 A GB 33481/76A GB 3348176 A GB3348176 A GB 3348176A GB 1525765 A GB1525765 A GB 1525765A
Authority
GB
United Kingdom
Prior art keywords
parts
injectable solution
aug
mixture
time
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB33481/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNION PHARMA SCIENT APPL
Original Assignee
UNION PHARMA SCIENT APPL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNION PHARMA SCIENT APPL filed Critical UNION PHARMA SCIENT APPL
Publication of GB1525765A publication Critical patent/GB1525765A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB33481/76A 1975-08-11 1976-08-11 Injectable solution Expired GB1525765A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7524981A FR2320759A1 (fr) 1975-08-11 1975-08-11 Solution d'acide acetylsalicylique extemporanee injectable

Publications (1)

Publication Number Publication Date
GB1525765A true GB1525765A (en) 1978-09-20

Family

ID=9158984

Family Applications (1)

Application Number Title Priority Date Filing Date
GB33481/76A Expired GB1525765A (en) 1975-08-11 1976-08-11 Injectable solution

Country Status (10)

Country Link
JP (1) JPS5241212A (ja)
AU (1) AU1673776A (ja)
BE (1) BE845038A (ja)
DE (1) DE2635843A1 (ja)
ES (1) ES450583A1 (ja)
FR (1) FR2320759A1 (ja)
GB (1) GB1525765A (ja)
NL (1) NL7608951A (ja)
SE (1) SE7608909L (ja)
ZA (1) ZA764781B (ja)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2240041B (en) * 1989-12-22 1993-09-01 Scras Agents for blocking endothelin derived relaxing factor
ES2052452A1 (es) * 1992-01-04 1994-07-01 Sod Conseils Rech Applic Procedimiento de preparacion de inhibidores duales de no-sintasa y ciclooxigenasa.
EP1739086A2 (en) * 2005-06-29 2007-01-03 Verisfield (UK) Ltd. Pharmaceutical compositions of risperidone in aqueous solution
CN101380329B (zh) * 2008-10-29 2010-11-17 海南本创医药科技有限公司 一种精氨酸阿司匹林及其粉针剂的制备方法
WO2010130396A3 (en) * 2009-05-11 2011-10-27 King Saud University Preparation of acetyl salicylic acid/glutamic acid complex for oral administration
US11369581B2 (en) 2016-06-28 2022-06-28 Asamedic As Two component composition
US11844806B2 (en) 2017-12-22 2023-12-19 Asamedic As Compositions comprising acetylsalicylic acid and a phosphate salt
US11850253B2 (en) 2017-12-22 2023-12-26 Asamedic As Two component compositions

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6021570B2 (ja) * 1978-07-04 1985-05-28 三共株式会社 ド−パ類の高濃度製剤の製法
FR2495608A1 (fr) * 1980-12-04 1982-06-11 Morelle Jean Nouveaux derives de l'acide aspartique et leurs usages
CN102531969A (zh) * 2011-12-28 2012-07-04 蚌埠丰原医药科技发展有限公司 一种无菌l-精氨酸的制备方法
WO2023198294A1 (en) * 2022-04-14 2023-10-19 Hyloris Developments Sa Acetyl salicylic acid composition for intravenous administration, its storage, production and use

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2240041B (en) * 1989-12-22 1993-09-01 Scras Agents for blocking endothelin derived relaxing factor
AT403122B (de) * 1989-12-22 1997-11-25 Sod Conseils Rech Applic Therapeutische infusionszubereitung auf basis von aminosäurederivaten
ES2052452A1 (es) * 1992-01-04 1994-07-01 Sod Conseils Rech Applic Procedimiento de preparacion de inhibidores duales de no-sintasa y ciclooxigenasa.
EP1739086A2 (en) * 2005-06-29 2007-01-03 Verisfield (UK) Ltd. Pharmaceutical compositions of risperidone in aqueous solution
EP1739086A3 (en) * 2005-06-29 2007-02-28 Verisfield (UK) Ltd. Pharmaceutical compositions of risperidone in aqueous solution
CN101380329B (zh) * 2008-10-29 2010-11-17 海南本创医药科技有限公司 一种精氨酸阿司匹林及其粉针剂的制备方法
WO2010130396A3 (en) * 2009-05-11 2011-10-27 King Saud University Preparation of acetyl salicylic acid/glutamic acid complex for oral administration
US11369581B2 (en) 2016-06-28 2022-06-28 Asamedic As Two component composition
US11918554B2 (en) 2016-06-28 2024-03-05 Asamedic As Two-component composition
US11844806B2 (en) 2017-12-22 2023-12-19 Asamedic As Compositions comprising acetylsalicylic acid and a phosphate salt
US11850253B2 (en) 2017-12-22 2023-12-26 Asamedic As Two component compositions

Also Published As

Publication number Publication date
FR2320759B1 (ja) 1979-09-14
NL7608951A (nl) 1977-02-15
ES450583A1 (es) 1978-02-01
DE2635843A1 (de) 1977-02-24
JPS5241212A (en) 1977-03-30
AU1673776A (en) 1978-02-16
FR2320759A1 (fr) 1977-03-11
ZA764781B (en) 1977-07-27
BE845038A (fr) 1976-12-01
SE7608909L (sv) 1977-02-12

Similar Documents

Publication Publication Date Title
GB1525765A (en) Injectable solution
ES426490A1 (es) Mejoras introducidas en barras de andamio.
AU504200B2 (en) Lean mixture i/c engine
CA1035147A (en) Chemical concentrate injection system
GB1457191A (en) Aromatic fluoro-polyimide adhesive compositions
MY7800043A (en) Carboxyethyl ester of n-phosphono-methyl glycine salts thereof,and their use as herbicides
AU470695B2 (en) Single anchor leg single point mooring system
AU8390375A (en) Administering amino acid ackyl esters
JPS5272026A (en) Air-to-fuel rate control system
CA1017202A (en) Fuel preparation system
IE39836L (en) Substituted amino-benzoic acid derivatives
IE41830L (en) N-acyl hydroxyphenyl glycines
IL45417A0 (en) The preparation of cyclopropane-carboxylic acid esters and substituted phenylacetic acid esters
GB1525907A (en) Ureidoacetohydroxamic acids
GB1158726A (en) Amino Acid Derivatives
JPS5214745A (en) Preparation of phenylcarbamic acid esters
AU499150B2 (en) Fuel injection system
CA947160A (en) Single fuel system carburetor having improved metering stability
FR2444048A1 (ja)
AU491601B2 (en) The transportation of coal by pipeline
JPS5422498A (en) Preparation of unsaturated polyester modified with epoxy resin
ES445144A1 (es) Procedimiento para la preparacion de compuestos derivados deindolobenzacepinas.
GB1295906A (ja)
CA937575A (en) Process for the preparation of lysine or of a lysine compound and of new compounds connected with this process
GB1398819A (en) Pharmaceutical compositions containing sulphoglycopeptide salts

Legal Events

Date Code Title Description
CSNS Application of which complete specification have been accepted and published, but patent is not sealed